Brief: Burning Rock Reports Third Quarter Loss Per Share $0.31
Nov 15 (Reuters) - Burning Rock Biotech Ltd BNR.O :
* BURNING ROCK REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* Q3 REVENUES WERE RMB154.6 MILLION (US$21.7 MILLION) A
22.1%
INCREASE FROM RMB126.6 MILLION FOR SAME PERIOD IN 2021.
* WE REVISE OUR 2022 FULL-YEAR REVENUE GUIDANCE TO A GROWTH
OF
APPROXIATELY 5% COMPARED TO 2021
* QTRLY LOSS PER SHARE $0.31
Source text for Eikon: ID:nGNX3x35mt
Further company coverage: BNR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Burning Rock Biotech
See all newsBurning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer